CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Xbiotech Inc.  (XBIT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Xbiotech's Leverage Ratio

XBIT's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

XBIT Leverage Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Equity Change -13.11 % -42.68 % -37.21 % -33.21 % -
Y / Y Total Liabilities Change -18.79 % 24.2 % 34.06 % 262.01 % -
Leverage Ratio MRQ 0.06 0.14 0.09 0.13 0.07
Overall Ranking # 106 # 265 # 163 # 261 # 145
Seq. Equity Change 39.29 % -17.54 % -13.5 % -12.54 % -8.12 %
Seq. Total Liabilities Change -33.06 % 19.86 % -35.91 % 57.94 % 2.38 %



Leverage Ratio first quarter 2017 Comment
Due to repayements of liabilities of -33.06% Xbiotech improved Leverage Ratio in first quarter 2017 to 0.06, below company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the first quarter 2017, 18 other companies have achieved lower Leverage Ratio than Xbiotech. While Leverage Ratio total ranking has improved so far to 106, from total ranking in previous quarter at 265.

Explain Leverage Ratio?
Who are XBIT Customers?
Leverage Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 19
Sector # 37
S&P 500 # 106


Leverage Ratio Statistics
High Average Low
0.14 0.08 0.02
(Dec 31 2016)   (Jun 30 2015)


You need to upgrade your Flash Player


Financial Statements
Xbiotech's Equity $ 82 Millions Visit XBIT's Balance sheet
Xbiotech's Total Liabilities $ 5 Millions Visit XBIT's Balance sheet
Source of XBIT's Sales Visit XBIT's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2017, within Major Pharmaceutical Preparations Industry Leverage RatioMar 31 2017 MRQ Total LiabilitiesMar 31 2017 MRQ Equity
Macrogenics Inc  0.18 $ 41.594  Millions$ 234.638  Millions
Immune Design Corp.  0.17 $ 14.816  Millions$ 85.066  Millions
Madrigal Pharmaceuticals, Inc.  0.17 $ 5.906  Millions$ 34.451  Millions
Glycomimetics Inc  0.17 $ 5.288  Millions$ 31.886  Millions
Corbus Pharmaceuticals Holdings, Inc.  0.16 $ 7.021  Millions$ 43.586  Millions
Revance Therapeutics, Inc.  0.15 $ 27.281  Millions$ 178.671  Millions
Checkpoint Therapeutics, Inc.  0.15 $ 4.308  Millions$ 28.901  Millions
Pharmathene, Inc  0.15 $ 2.677  Millions$ 18.051  Millions
Biostar Pharmaceuticals, Inc.  0.15 $ 5.311  Millions$ 36.182  Millions
Five Prime Therapeutics Inc  0.15 $ 52.032  Millions$ 357.049  Millions
Biospecifics Technologies Corp  0.14 $ 8.656  Millions$ 59.697  Millions
Stemline Therapeutics Inc  0.14 $ 13.330  Millions$ 93.216  Millions
Medicinova Inc  0.14 $ 4.673  Millions$ 32.751  Millions
Beigene, Ltd.  0.14 $ 43.849  Millions$ 308.417  Millions
Tetraphase Pharmaceuticals Inc  0.14 $ 16.365  Millions$ 118.992  Millions
Prophase Labs, Inc.  0.14 $ 6.873  Millions$ 50.670  Millions
United Therapeutics Corp  0.13 $ 277.900  Millions$ 2,065.300  Millions
Prothena Corp Plc  0.13 $ 63.992  Millions$ 496.248  Millions
Therapeuticsmd, Inc.  0.13 $ 14.087  Millions$ 110.334  Millions
Aldeyra Therapeutics, Inc.  0.13 $ 3.537  Millions$ 27.995  Millions
Dermira, Inc.  0.13 $ 50.675  Millions$ 405.096  Millions
Karyopharm Therapeutics Inc.  0.12 $ 17.072  Millions$ 138.363  Millions
Nivalis Therapeutics, Inc.  0.12 $ 6.040  Millions$ 49.220  Millions
Ovascience, Inc.  0.12 $ 11.597  Millions$ 94.722  Millions
Ardelyx, Inc.  0.12 $ 20.081  Millions$ 167.684  Millions
Mirati Therapeutics, Inc.  0.12 $ 11.649  Millions$ 99.116  Millions
Ultragenyx Pharmaceutical Inc.  0.12 $ 57.344  Millions$ 488.478  Millions
Chiasma, Inc  0.11 $ 8.998  Millions$ 79.427  Millions
Cellectar Biosciences, Inc.  0.11 $ 1.548  Millions$ 13.749  Millions
Myovant Sciences Ltd.  0.11 $ 18.502  Millions$ 166.776  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com